Enhancement in dopamine reduces generous behaviour in women


Autoři: Sergio Oroz Artigas aff001;  Lu Liu aff001;  Sabrina Strang aff001;  Caroline Burrasch aff001;  Astrid Hermsteiner aff001;  Thomas F. Münte aff004;  Soyoung Q. Park aff001
Působiště autorů: Department of Psychology, University of Lübeck, Lübeck, Germany aff001;  Department of Decision Neuroscience & Nutrition, German Institute of Human Nutrition, Nuthetal, Germany aff002;  Deutsches Zentrum für Diabetes, Neuherberg, Germany aff003;  Department of Neurology, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany aff004;  Neuroscience Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany aff005
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pone.0226893

Souhrn

Generosity is a human behavior common in social contexts. However, humans are not equally generous to everyone alike. Instead, generosity decreases as a function of social distance, an effect called social discounting. Studies show that such social discounting effect depends on diverse factors including personality traits, cultures, stress or hormonal levels. Recently, the importance of the neurotransmitter dopamine in regulating social interactions has been highlighted. However, it remains unclear how exactly dopamine agonist administration modulates generous behavior as a function of social discounting. Here, we investigate the causal effect of dopamine agonist administration on social discounting in a pharmacological intervention study. We employ a randomized, double-blind, within-subject design to investigate the impact of the D2/D3 receptor agonist pramipexole on social discounting by keeping gender constant. We apply hyperbolic social discount model to the data and provide evidence that women under pramipexole become less generous in general, especially towards close others. Our results highlight the crucial role of dopamine in social decision making.

Klíčová slova:

Behavior – Cognition – Decision making – Dopamine – Dopaminergics – Drug administration – Oxytocin – Prosocial behavior


Zdroje

1. Park SQ, Kahnt T, Dogan A, Strang S, Fehr E, Tobler PN. A neural link between generosity and happiness. Nature Communications. 2017 Jul 11. doi: 10.1038/ncomms15964 28696410

2. Strang S, Park SQ. Human Cooperation and Its Underlying Mechanisms (pp. 223–239). Springer, Cham; 2016. doi: 10.1007/7854_2016_445. 27356520

3. Strombach T, Weber B, Hangebrauk Z, Kenning P, Karipidis II, Tobler PN, et al. Social discounting involves modulation of neural value signals by temporoparietal junction. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112: 1619–1624. doi: 10.1073/pnas.1414715112 25605887

4. Strang S, Gerhardt H, Marsh N, Oroz Artigas S, Hu Y, Hurlemann R, et al. A matter of distance-The effect of oxytocin on social discounting is empathy-dependent. Psychoneuroendocrinology. 2017; 78: 229–232. doi: 10.1016/j.psyneuen.2017.01.031 28219815

5. Strombach T, Margittai Z, Gorczyca B, Kalenscher T. Gender-Specific Effects of Cognitive Load on Social Discounting. PloS One. 2016; 11: e0165289. doi: 10.1371/journal.pone.0165289 27788192

6. Strombach T, Jin J, Weber B, Kenning P, Shen Q, Ma Q, et al. Charity Begins at Home: Cultural Differences in Social Discounting and Generosity. Journal of Behavioral Decision Making. 2014; 27: 235–245. doi: 10.1002/bdm.1802

7. Margittai Z, Strombach T, Van Wingerden M, Joëls M, Schwabe L, Kalenscher T. A friend in need: Time-dependent effects of stress on social discounting in men. Hormones and Behavior. 2015; 73: 75–82. doi: 10.1016/j.yhbeh.2015.05.019 26122295

8. Margittai Z, van Wingerden M, Schnitzler A, Joëls M, Kalenscher T. Dissociable roles of glucocorticoid and noradrenergic activation on social discounting. Psychoneuroendocrinology. 2018; 90: 22–28. doi: 10.1016/j.psyneuen.2018.01.015 29407513

9. Schultz W. Multiple Dopamine Functions at Different Time Courses. Annual Review of Neuroscience. 2007; 30: 259–288. doi: 10.1146/annurev.neuro.28.061604.135722 17600522

10. Sáez I, Zhu L, Set E, Kayser A, Hsu M. Dopamine modulates egalitarian behavior in humans. Current Biology. 2015; 25: 912–919. doi: 10.1016/j.cub.2015.01.071 25802148

11. Burke CJ, Soutschek A, Weber S, Raja Beharelle A, Fehr E, Haker H, et al. Dopamine Receptor-Specific Contributions to the Computation of Value. Neuropsychopharmacology. 2018; 43: 1415–1424. doi: 10.1038/npp.2017.302 29251282

12. Joutsa J, Voon V, Johansson J, Niemelä S, Bergman J, Kaasinen V. Dopaminergic function and intertemporal choice. Translational Psychiatry. 2015; 5: e491. doi: 10.1038/tp.2014.133 25562841

13. Martinez D, Orlowska D, Narendran R, Slifstein M, Liu F, Kumar D, et al. Dopamine Type 2/3 Receptor Availability in the Striatum and Social Status in Human Volunteers. Biological Psychiatry. 2010; 67: 275–278. doi: 10.1016/j.biopsych.2009.07.037 19811777

14. Soutschek A, Burke CJ, Raja Beharelle A, Schreiber R, Weber SC, Karipidis II, et al. The dopaminergic reward system underpins gender differences in social preferences. Nature Human Behaviour. 2017; 1: 819. doi: 10.1038/s41562-017-0226-y 31024122

15. Rand DG, Brescoll VL, Everett JA, Capraro V, Barcelo H. Social heuristics and social roles: Intuition favors altruism for women but not for men. Journal of Experimental Psychology: General. 2016; 145: 389. doi: 10.1037/xge0000154 26913619

16. Strang S, Hoeber C, Uhl O, Koletzko B, Münte TF, Lehnert H, et al. Impact of nutrition on social decision making. Proceedings of the National Academy of Sciences of the United States of America. 2017; 114: 6510–6514. doi: 10.1073/pnas.1620245114 28607064

17. Bennett JP, Piercey MF. Pramipexole—a new dopamine agonist for the treatment of Parkinson’s disease. Journal of the Neurological Sciences. 1999; 163: 25–31. doi: 10.1016/s0022-510x(98)00307-4 10223406

18. Pedroni A, Eisenegger C, Hartmann MN, Fischbacher U, Knoch D. Dopaminergic stimulation increases selfish behavior in the absence of punishment threat. Psychopharmacology.2014; 231: 135–141. doi: 10.1007/s00213-013-3210-x 23900641

19. Aydogan G, Furtner NC, Kern B, Jobst A, Müller N, Kocher MG. Oxytocin promotes altruistic punishment. Social cognitive and affective neuroscience. 2017; 12: 1740–1747. doi: 10.1093/scan/nsx101 28981891

20. De Dreu CK, Greer LL, Handgraaf MJ, Shalvi S, Van Kleef GA, Baas M, et al. The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science. 2010; 328: 1408–1411. doi: 10.1126/science.1189047 20538951

21. Crockett MJ, Siegel JZ, Kurth-Nelson Z, Ousdal OT, Story G, Frieband C, et al. Dissociable effects of serotonin and dopamine on the valuation of harm in moral decision making. Current Biology. 2015; 25: 1852–1859. doi: 10.1016/j.cub.2015.05.021 26144968

22. Sáez I, Zhu L, Set E, Kayser A, Hsu M. Dopamine modulates egalitarian behavior in humans. Current Biology. 2015; 25: 912–919. doi: 10.1016/j.cub.2015.01.071 25802148

23. Ye Z, Hammer A, Camara E, Münte TF. Pramipexole modulates the neural network of reward anticipation. Human Brain Mapping. 2011; 32: 800–811. doi: 10.1002/hbm.21067 21484950

24. Antonelli F, Ko JH, Miyasaki J, Lang AE, Houle S, Valzania F, et al. Dopamine-agonists and impulsivity in Parkinson’s disease: impulsive choices vs. impulsive actions. Human Brain Mapping. 2014; 35: 2499–2506. doi: 10.1002/hbm.22344 24038587

25. Schapira AHV, McDermott MP, Barone P, Comella CL, Albrecht S, Hsu HH, et al. Pramipexole in patients with early Parkinson’s disease (PROUD): a randomised delayed-start trial. The Lancet Neurology. 2013; 12: 747–755. doi: 10.1016/S1474-4422(13)70117-0 23726851

26. Costa A, Peppe A, Dell’Agnello G, Caltagirone C, Carlesimo GA. Dopamine and cognitive functioning in de novo subjects with Parkinson’s disease: Effects of pramipexole and pergolide on working memory. Neuropsychologia. 2009; 47: 1374–1381. doi: 10.1016/j.neuropsychologia.2009.01.039 19428401

27. O’Sullivan SS, Evans AH, Quinn NP, Lawrence AD, Lees AJ. Reckless generosity in Parkinson’s disease. Movement Disorders. 2010; 25: 221–223. doi: 10.1002/mds.22687 20077470

28. Huys QJ, Pizzagalli DA, Bogdan R, Dayan P. Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis. Biology of Mood & Anxiety Disorders. 2013; 3: 12. doi: 10.1186/2045-5380-3-12 23782813

29. Colzato LS, Hommel B. Effects of estrogen on higher-order cognitive functions in unstressed human females may depend on individual variation in dopamine baseline levels. Frontiers in neuroscience. 2014; 8: 65. doi: 10.3389/fnins.2014.00065 24778605

30. Jacobs E, D'Esposito M. Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. Journal of Neuroscience. 2011; 31: 5286–5293. doi: 10.1523/JNEUROSCI.6394-10.2011 21471363

31. Ioannidis JP. Clarifications on the application and interpretation of the test for excess significance and its extensions. Journal of Mathematical Psychology. 2013; 57: 184–187. doi: 10.1016/j.jmp.2013.03.002

32. Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience. 2013; 14: 365–376. doi: 10.1038/nrn3475 23571845


Článok vyšiel v časopise

PLOS One


2019 Číslo 12